Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
Odrade Gondry, Catarina Xavier, Laurens Raes, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 9, pp. 1378-1384
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

CD45-PET is a robust, non-invasive tool for imaging inflammation
Ali Salehi Farid, Jennifer E. Rowley, Harris H. Allen, et al.
Nature (2025) Vol. 639, Iss. 8053, pp. 214-224
Closed Access | Times Cited: 4
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 10
Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
Liudmyla Maksymova, Yannick A. Pilger, Lutz Nuhn, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Current status and future expectations of nanobodies in oncology trials
Tessa De Pauw, Lynn De Mey, Jens Debacker, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 705-721
Open Access | Times Cited: 18
Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
Katty Zeven, Timo W. M. De Groof, Hannelore Ceuppens, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management
Ying Cong, Nick Devoogdt, Philippe Lambin, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 371-371
Open Access | Times Cited: 4
Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers
Katty Zeven, Herlinde Dierick, Matthijs B. Sevenois, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Enhancing theranostic potential of anti-mesothelin sdAb through site-specific labeling at a unique conserved lysine by molecular engineering
Emilien N’Guessan, Florian Raes, Mitra Ahmadi, et al.
EJNMMI Radiopharmacy and Chemistry (2025) Vol. 10, Iss. 1
Open Access
SPECT Imaging of Cardiac Inflammation by Targeting IL4 Receptor-α on Macrophages
Danzha Zheng, Mengyan Hu, Wenwen Wang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Evaluation of ImmunoPET in the efficacy and prognosis of immunotherapy for lung cancer
Yiran Liang, Mei Xie, Xuefeng Zang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189289-189289
Closed Access
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers
Dandan Li, Udo Rudloff
Expert Opinion on Emerging Drugs (2025)
Open Access
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer
Herlinde Dierick, Laurent Navarro, Hannelore Ceuppens, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Diagnostic Performance of MRI and FDG PET/CT for Preoperative Locoregional Staging of Colon Cancer: Systematic Review and Meta-Analysis
Daan J. Sikkenk, Isabelle J. Henskens, Bart van de Laar, et al.
American Journal of Roentgenology (2024)
Closed Access | Times Cited: 3
Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer
Yoline Lauwers, Timo W. M. De Groof, Cécile Vincke, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 52
Open Access | Times Cited: 3
Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics
Qian Zhang, Nan Zhang, Han Xiao, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5639-5639
Open Access | Times Cited: 7
Advances and challenges in immunoPET methodology
Philipp Mohr, Joyce van Sluis, Marjolijn N. Lub–de Hooge, et al.
Frontiers in Nuclear Medicine (2024) Vol. 4
Open Access | Times Cited: 2
Advancements in Nuclear Imaging Using radiolabeled Nanobody tracers to support Cancer Immunotherapy
Katty Zeven, Yoline Lauwers, Lynn De Mey, et al.
Immunotherapy Advances (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Recent advancements in new tracers from first-in-human studies
Yuji Nakamoto, Yoshitaka Inui, Masatoshi Hotta, et al.
Annals of Nuclear Medicine (2024)
Open Access | Times Cited: 2
Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
Jonatan Dewulf, Sam Massa, Laurent Navarro, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs
Nayra Cristina Herreira do Valle, Simone Janssen, Marcus C. M. Stroet, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Making the effect visible – OX40 targeting nanobodies for in vivo imaging of activated T cells
Desiree I. Frecot, Simone Blaess, Teresa R. Wagner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Molecular imaging for better theranostics
Dawei Jiang, Weijun Wei
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 13, pp. 3799-3801
Open Access | Times Cited: 3
Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice
Putri Andriana, Ruth Fair-Mäkelä, Heidi Liljenbäck, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2216-2228
Open Access
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of Fibroblast Activation Protein-α or Folate Receptor-α overexpression in cancer
Herlinde Dierick, Laurent Navarro, Hannelore Ceuppens, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1 - Next Page

Scroll to top